Should I invest in UTI - Equity Fund?

We don't give personal investment advice. UTI - Equity Fund-Growth Option is suitable for an investor whose:time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a lossrisk tolerance accepts seeing the portfolio fall sharply without panic-sellinggoal isn't capital preservation in the short termCross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 25.9%. 5-year CAGR: 6.14%.

UTI

UTI - Equity Fund-Growth Option

Latest NAV

₹318.2605

As of

17 Jul 2026

4,988 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	-0.12%	+0.13%	-0.25	70 / 75	Q4
1W	+0.57%	+0.04%	+0.53	13 / 74	Q1
2W	+1.64%	-0.03%	+1.68	6 / 73	Q1
1M	+3.65%	+1.15%	+2.50	9 / 72	Q1
3M	+6.78%	+4.98%	+1.81	20 / 71	Q2
6M	+0.39%	+8.01%	-7.62	48 / 71	Q3
YTD	-1.09%	+3.91%	-5.00	49 / 71	Q3
1Y	-2.56%	+15.10%	-17.66	58 / 65	Q4
2Y	+1.55%	+7.99%	-6.44	42 / 61	Q3
3Y	+8.08%	+11.25%	-3.17	38 / 55	Q3
4Y	+9.15%	+11.82%	-2.67	21 / 35	Q3
5Y	+6.14%	+10.79%	-4.65	27 / 33	Q4
7Y	+12.97%	+12.57%	+0.41	13 / 28	Q2
10Y	+11.53%	+10.43%	+1.10	13 / 28	Q2
Inception	+11.83%	+9.06%	+2.77	27 / 75	Q2

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2026 YTD	-1.09%	-1.05%	-0.05	15 / 27
2025	+0.46%	+2.13%	-1.68	20 / 27
2024	+14.48%	+17.60%	-3.12	18 / 27
2023	+19.68%	+25.30%	-5.62	22 / 27
2022	-13.42%	+0.84%	-14.26	31 / 32
2021	+33.17%	+25.14%	+8.02	11 / 46
2020	+31.30%	+13.07%	+18.22	5 / 50
2019	+11.56%	+4.14%	+7.42	8 / 61
2018	+4.37%	-7.56%	+11.92	1 / 36
2017	+29.31%	+31.98%	-2.67	23 / 36
2016	+0.74%	+1.09%	-0.34	17 / 38

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+15.07%

236 windows

min -45.6% · max 94.6%

77% positive

3-Year rolling

+13.84%

210 windows

min -4.3% · max 31.2%

99% positive

5-Year rolling

+13.86%

187 windows

min 3.2% · max 22.1%

100% positive

7-Year rolling

+13.84%

163 windows

min 8.6% · max 21.1%

100% positive

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

13.60%

3-year · annualised

Sharpe ratio

0.16

vs risk-free 6.5%

Sortino ratio

0.25

Downside-only deviation

Max drawdown

-20.83%

Sep 2024 → Mar 2026

% positive months

50.0%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Flexi Cap Fund

Scheme	Fund house	NAV	As of
HDFC Equity Fund - Dividend Option	HDFC	₹73.8450	17 Jul 2026
SBI Magnum Multicap Fund - Dividend Option	SBI	₹48.2854	17 Jul 2026
ICICI Prudential Flexicap Fund - Growth	ICICI Prudential	₹19.9500	17 Jul 2026
Franklin India Prima Plus-Dividend	Franklin Templeton	₹62.3718	17 Jul 2026
Kotak Flexicap Fund - Growth	Kotak	₹85.9620	17 Jul 2026
HSBC India Opportunities Fund - Dividend	HSBC	₹42.2405	17 Jul 2026
Canara Robeco Equity Diversified-Growth	Canara Robeco	₹342.0300	17 Jul 2026
UTI - Equity Fund-Income Option	UTI	₹210.4136	17 Jul 2026
Birla Sun Life Equity Fund-Plan A(Dividend)	Birla Sun Life	₹165.6000	17 Jul 2026
Escorts Power & Energy Fund - Dividend Option	Escorts	₹77.6979	17 Jul 2026

Recent NAVs

Date	NAV
17 Jul 2026	₹318.2605
16 Jul 2026	₹318.6405
15 Jul 2026	₹317.1343
14 Jul 2026	₹315.2875
13 Jul 2026	₹316.8053
10 Jul 2026	₹316.4588
9 Jul 2026	₹313.9229
8 Jul 2026	₹311.4727
7 Jul 2026	₹317.2739
6 Jul 2026	₹315.7428

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 17 Jul 2026, the NAV of UTI - Equity Fund-Growth Option is ₹318.2605. It's a Flexi Cap Fund from UTI, run as a Unknown plan Growth option. NAVs update once per business day from the AMFI feed.

UTI - Equity Fund-Growth Option has NAV history starting from 03 Apr 2006, a track record of about 20 years 3 months. Long-tenured funds like this have weathered multiple market cycles — the 2008 crash, 2013 taper tantrum, 2020 COVID drawdown — which makes their returns more credible than a 3-year track record alone.

UTI - Equity Fund-Growth Option is managed by UTI. It's classified by AMFI under the 'Flexi Cap Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI - Equity Fund-Growth Option has delivered a absolute return of -2.56% — -17.66 pp behind the Flexi Cap Fund category average of 15.10%. The fund ranks #58 of 65 in its category — the bottom (Q4) quartile.

Over the trailing 3-year window, UTI - Equity Fund-Growth Option has delivered a CAGR of 8.08% — -3.17 pp behind the Flexi Cap Fund category average of 11.25%. The fund ranks #38 of 55 in its category — the third (Q3) quartile.

Over the trailing 5-year window, UTI - Equity Fund-Growth Option has delivered a CAGR of 6.14% — -4.65 pp behind the Flexi Cap Fund category average of 10.79%. The fund ranks #27 of 33 in its category — the bottom (Q4) quartile.

₹1 lakh invested in UTI - Equity Fund-Growth Option exactly 10 years ago would be worth approximately ₹297,731 today — a multiplier of 2.98×, based on the 10-year CAGR of 11.53%. The category average over the same window would have grown ₹1 lakh to ₹269,598.

A ₹10,000 monthly SIP in UTI - Equity Fund-Growth Option over the last 5 years — total invested ₹600,000 — would be worth ₹704,125 today. That's an XIRR (money-weighted annualised return) of 6.34%.

A ₹10,000 monthly SIP for 10 years in UTI - Equity Fund-Growth Option = ₹1,200,000 invested. It would currently be worth ₹2,108,355 (multiplier 1.76×). XIRR: 10.85%. Long-horizon SIP results matter more than point-to-point returns because they smooth out entry timing.

On a 5-year basis, UTI - Equity Fund-Growth Option ranks #27 out of 33 funds in the Flexi Cap Fund category — that places it in the bottom quartile (Q4) — material underperformance. The category average return over the same window is 10.79%; this fund delivered 6.14%.

The worst peak-to-trough decline UTI - Equity Fund-Growth Option has experienced over the last 5-year window is 25.93% — its NAV fell from a high on 16 Nov 2021 to a low on 17 Jun 2022. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 5-year rolling windows, UTI - Equity Fund-Growth Option averaged 13.86% (best 22.15%, worst 3.22%). 100% of rolling windows ended positive. The 5-year Sharpe ratio is 0.04 — weak risk-adjusted performance.

In calendar year 2025, UTI - Equity Fund-Growth Option returned 0.46% — lagging the Flexi Cap Fund category average of 2.13% by 1.68 pp. It ranked #20 of 27 in its category that year.

UTI - Equity Fund-Growth Option is classified as an Equity fund (at least 65% equity exposure). Tax rules (post Budget 2024): if you hold 12 months or more, gains are Long-Term and taxed at 12.5% on the amount exceeding ₹1.25 lakh per financial year. Held for under 12 months, gains are Short-Term and taxed at 20%. The ₹1.25 L exemption is per PAN per FY across all equity LTCG.

We don't give personal investment advice. UTI - Equity Fund-Growth Option is suitable for an investor whose:

time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a loss
risk tolerance accepts seeing the portfolio fall sharply without panic-selling
goal isn't capital preservation in the short term

Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 25.9%. 5-year CAGR: 6.14%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.